1 not yet recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Not yet recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Biotroy Therapeutics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Study of BT02 in Patients With Relapsed or Refractory Hematologic Malignancies BT02 - Relapsed or Refractory Hematologic Malignancies, Leukemia | Phase 1 / Phase 2 | Not yet recruiting | Biotroy Therapeutics | 116 | 2025-10-01 | 2025-09-17 |
Hematologic Neoplasms (1) · Leukemia (1) · Lymphoma (1) · Multiple Myeloma (1) · Recurrence (1)
Ying Wang, MD (1)